COVID-19 is fueling a boom for cosmetic surgery and non-surgical cosmetic procedures as Zoom Dysmorphia is driving people to improve their appearances after staring at themselves on a screen for the better part of almost a year and half. In fact, the American Society of Plastic Surgeons reports that 11% of women surveyed are more interested in cosmetic plastic surgery and non-surgical procedures now than before COVID. The numbers jump for those that have previously had procedures. Ever/Body is a provider of cosmetic dermatology services and beauty treatments in two sleek Manhattan locations (Flatiron and Soho). The company, founded in 2018, offers a full range of minimally invasive dermatological treatments including Botox, Fillers, Contouring, Laser Facials, Microneedling, and Laser Hair Removal. In addition to treatments, Ever/Body also offers a full line of curated skincare products. Accessing dermatological services in populous areas like New York can be time-consuming and expensive but with Ever/Body you can easily make an appointment online to see vetted professionals quickly and affordably to get a rejuvenated look in under an hour. AlleyWatch caught up with CEO Amy Shecter to learn more about the business, the company’s future plans, latest round of funding from investors that include Tiger Global Management, Addition, Fifth Wall, MetaProp, Gaingels, Declaration Partners, ACME Capital, and Redesign Health.